Stay updated on CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial
Sign up to get notified when there's something new on the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page.

Latest updates to the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now lists new MAP entries for CTL019 and describes the overall MAP purpose and eligibility, while removing the previous Out of Specification MAP details; together, these changes expand and refresh how access programs are presented on the page.SummaryDifference18%

- Check25 days agoChange DetectedThe page footer was updated from Revision v3.5.0 to Revision v3.5.2.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check97 days agoChange DetectedAdded Revision: v3.4.1. Deleted the funding-lapse notice and Revision: v3.4.0.SummaryDifference0.1%

Stay in the know with updates to CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTL019 Out of Spec MAP in ALL/DLBCL Clinical Trial page.